Baxter's Icodextrin
This article was originally published in The Gray Sheet
Executive Summary
New drug application for the peritoneal dialysis solution is filed with FDA. The product has the potential to remove more fluid from the bloodstream during long-dwell dialysis than conventional solutions, Baxter claims. The solution has been marketed in Europe for four years